By Armen Hareyan on May 23, 2007 - 12:23pm 
for eMaxHealth
for eMaxHealthSmall Cell Lung Cancer Trial
Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.
Details are as follows:
-- Abstract #7722, Poster #EE3
Source:
Poniard Pharmaceuticals, Inc. eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.
